• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1014

2’-fucosyllactose

Intended Use: Intended for use as an ingredient at a level of 2.4 g/L in formula for young children (> 12 months); at a level of 12 g/kg (or g/L) in milk- and soy-based meal replacement beverages for children, ready-to-serve and dry instant cereals for infants and young children, meal replacement drinks, meal replacement bars, snack bars, and breakfast bars; at a level of 6 g/L in non-carbonated sports drinks and flavored waters; and at a level of 20 g/L in enteral tube feeding formulas.
Basis: Scientific procedures
Notifier: Chr. Hansen, Inc.
Notifier Address: 9015 West Maple Street
Milwaukee, WI 53214
GRAS Notice (releasable information): GRN 1014 (4.6 MB)
Date of closure: Jul 15, 2022
FDA's Letter: FDA has no questions (in PDF) (295 kB)

96  

-
-